These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38372700)

  • 1. M6A modification regulates tumor suppressor DIRAS1 expression in cervical cancer cells.
    Wang YY; Ye LH; Zhao AQ; Gao WR; Dai N; Yin Y; Zhang X
    Cancer Biol Ther; 2024 Dec; 25(1):2306674. PubMed ID: 38372700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the function and mechanism of DIRAS1 in osteosarcoma.
    Liu H; Shu W; Liu T; Li Q; Gong M
    Tissue Cell; 2022 Jun; 76():101794. PubMed ID: 35413492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. piRNA-14633 promotes cervical cancer cell malignancy in a METTL14-dependent m6A RNA methylation manner.
    Xie Q; Li Z; Luo X; Wang D; Zhou Y; Zhao J; Gao S; Yang Y; Fu W; Kong L; Sun T
    J Transl Med; 2022 Jan; 20(1):51. PubMed ID: 35093098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. E6E7 regulates the HK2 expression in cervical cancer via GSK3β/FTO signal.
    Liu C; Li Y; Dong C; Qu L; Zuo Y
    Arch Biochem Biophys; 2022 Oct; 729():109389. PubMed ID: 36075458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylation of
    Zheng R; Gao D; He T; Zhang M; Zhang X; Linghu E; Wei L; Guo M
    Clin Epigenetics; 2017; 9():50. PubMed ID: 28491151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of the novel tumor suppressor DIRAS1 predicts poor prognosis in esophageal squamous cell carcinoma.
    Zhu YH; Fu L; Chen L; Qin YR; Liu H; Xie F; Zeng T; Dong SS; Li J; Li Y; Dai Y; Xie D; Guan XY
    Cancer Res; 2013 Apr; 73(7):2298-309. PubMed ID: 23436800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin attenuates multiple myeloma cell proliferation and encourages apoptosis by suppressing METTL3-mediated m6A methylation of THRAP3, RBM25, and USP4.
    Chen CJ; Huang JY; Huang JQ; Deng JY; Shangguan XH; Chen AZ; Chen LT; Wu WH
    Cell Cycle; 2023 Apr; 22(8):986-1004. PubMed ID: 36762777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive characterization of tumor microenvironment and m6A RNA methylation regulators and its effects on PD-L1 and immune infiltrates in cervical cancer.
    Ji H; Zhang JA; Liu H; Li K; Wang ZW; Zhu X
    Front Immunol; 2022; 13():976107. PubMed ID: 36091006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucose Is Involved in the Dynamic Regulation of m6A in Patients With Type 2 Diabetes.
    Yang Y; Shen F; Huang W; Qin S; Huang JT; Sergi C; Yuan BF; Liu SM
    J Clin Endocrinol Metab; 2019 Mar; 104(3):665-673. PubMed ID: 30137347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive Analysis of N6-Methyladenosine (m6A) Writers, Erasers, and Readers in Cervical Cancer.
    Condic M; Ralser DJ; Klümper N; Ellinger J; Qureischi M; Egger EK; Kristiansen G; Mustea A; Thiesler T
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemical Inhibitors Targeting the Oncogenic m
    Huang Y; Xia W; Dong Z; Yang CG
    Acc Chem Res; 2023 Nov; 56(21):3010-3022. PubMed ID: 37889223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The m6A demethylase FTO promotes the growth of lung cancer cells by regulating the m6A level of USP7 mRNA.
    Li J; Han Y; Zhang H; Qian Z; Jia W; Gao Y; Zheng H; Li B
    Biochem Biophys Res Commun; 2019 May; 512(3):479-485. PubMed ID: 30905413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. METTL3-mediated HSPA9 m6A modification promotes malignant transformation and inhibits cellular senescence by regulating exosomal mortalin protein in cervical cancer.
    Ao K; Yin M; Lyu X; Xiao Y; Chen X; Zhong S; Wen X; Yuan J; Ye M; Zhang J; Li X; Hao Y; Guo X
    Cancer Lett; 2024 Apr; 587():216658. PubMed ID: 38253218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FTO promotes cervical cancer cell proliferation, colony formation, migration and invasion via the regulation of the BMP4/Hippo/YAP1/TAZ pathway.
    Huang J; Yang J; Zhang Y; Lu D; Dai Y
    Exp Cell Res; 2023 Jun; 427(1):113585. PubMed ID: 37030332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HDAC3-dependent transcriptional repression of FOXA2 regulates FTO/m6A/MYC signaling to contribute to the development of gastric cancer.
    Yang Z; Jiang X; Zhang Z; Zhao Z; Xing W; Liu Y; Jiang X; Zhao H
    Cancer Gene Ther; 2021 Feb; 28(1-2):141-155. PubMed ID: 32655129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulated FTO and ALKBH5 co-operatively activates FOXO signaling through m6A methylation modification in HK2 mRNA mediated by IGF2BP2 to enhance glycolysis in colorectal cancer.
    Ye M; Chen J; Lu F; Zhao M; Wu S; Hu C; Yu P; Kan J; Bai J; Tian Y; Tang Q
    Cell Biosci; 2023 Aug; 13(1):148. PubMed ID: 37580808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ibuprofen promotes p75 neurotrophin receptor expression through modifying promoter methylation and N6-methyladenosine-RNA-methylation in human gastric cancer cells.
    Jin H; Wu Z; Tan B; Liu Z; Zu Z; Wu X; Bi Y; Hu X
    Bioengineered; 2022 Jun; 13(6):14595-14604. PubMed ID: 35758042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Tumor-suppressive Small GTPase DiRas1 Binds the Noncanonical Guanine Nucleotide Exchange Factor SmgGDS and Antagonizes SmgGDS Interactions with Oncogenic Small GTPases.
    Bergom C; Hauser AD; Rymaszewski A; Gonyo P; Prokop JW; Jennings BC; Lawton AJ; Frei A; Lorimer EL; Aguilera-Barrantes I; Mackinnon AC; Noon K; Fierke CA; Williams CL
    J Biol Chem; 2016 Mar; 291(12):6534-45. PubMed ID: 26814130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant Hypermethylation of SALL3 with HPV Involvement Contributes to the Carcinogenesis of Cervical Cancer.
    Wei X; Zhang S; Cao D; Zhao M; Zhang Q; Zhao J; Yang T; Pei M; Wang L; Li Y; Yang X
    PLoS One; 2015; 10(12):e0145700. PubMed ID: 26697877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knockdown of BRCC3 exerts an anti‑tumor effect on cervical cancer in vitro.
    Zhang F; Zhou Q
    Mol Med Rep; 2018 Dec; 18(6):4886-4894. PubMed ID: 30272359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.